We are live on
!
Find out more
Lineage Cell Therapeutics
LCTX
LCTX
80 hedge funds and large institutions have $152M invested in Lineage Cell Therapeutics in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
170% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 10
75% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 8
53% more capital invested
Capital invested by funds: $99.9M → $152M (+$52.5M)
8% more funds holding
Funds holding: 74 → 80 (+6)
0.61% more ownership
Funds ownership: 42.79% → 43.4% (+0.61%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
68% less call options, than puts
Call options by funds: $103K | Put options by funds: $318K
Holders
80
Holders Change
+6
Holders Change %
+8.11%
% of All Funds
2.13%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
27
Reduced
10
Closed
8
Calls
$103K
Puts
$318K
Net Calls
-$215K
Net Calls Change
+$26K
Top Buyers
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$869K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$647K |
| 3 |
Jane Street
New York
|
+$267K |
| 4 |
State Street
Boston,
Massachusetts
|
+$222K |
| 5 |
D.E. Shaw & Co
New York
|
+$206K |
Top Sellers
| 1 |
PCM
Pointe Capital Management
Grosse Pointe Farms,
Michigan
|
-$204K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$123K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$75.8K |
| 4 |
ST
Spot Trading
Chicago,
Illinois
|
-$60.3K |
| 5 |
Wolverine Trading
Chicago,
Illinois
|
-$58K |
